Author Response: Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
Shek Man Chim(Regeneron (United States)), Harikiran Nistala(Icahn School of Medicine at Mount Sinai), Alan R. Shuldiner(Regeneron (United States)), John Dronzek(Regeneron (United States)), Jonas Bovijn(Regeneron (United States)), Luca Lotta(Regeneron (United States)), Cristopher V. Van Hout(Regeneron (United States)), Adam E. Locke(James S. McDonnell Foundation), Anthony Marcketta(Regeneron (United States)), Susannah Brydges(Regeneron (United States)), Kristen E. Howell(Texas A&M University), Tanima De(Regeneron (United States)), Vinayagam Arunachalam(Regeneron (United States)), Katia Karalis(Regeneron (United States)), David J. Carey(Geisinger Medical Center), Olle Melander(Lund University), Michelle G. LeBlanc(Toronto General Hospital), Weizhen Wu(Third Affiliated Hospital of Guangzhou Medical University), Bin Ye(Regeneron (United States)), Alexander Li(Regeneron (United States)), Manuel Allen Revez Ferreira(Regeneron (United States)), Aris N. Economides(Regeneron (United States)), Lyndon J. Mitnaul(Regeneron (United States)), Niek Verweij(Regeneron (United States))
Cited by 0
Related Papers
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
|Circulation Research|2017|1.2k
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775